QualityStocksNewsBreaks Archives - Page 238 of 1429

FridaySep 15, 2023 12:26 pm

QualityStocksNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Looks Forward to Acclaim-3 Trial on Heels of Receipt of FDA FTD and ODD Designations

Genprex (NASDAQ: GNPX) is a clinical-stage gene therapy company focused on developing life-changing treatments for patients with cancer and diabetes. The company recently announced that the United States Food and Drug Administration (“FDA”) had granted Orphan Drug Designation (“ODD”) to its lead drug candidate, REQORSA(R) Immunogene Therapy (quratusugene ozeplasmid), for the treatment of small cell lung cancer (“SCLC”). The receipt of the ODD followed the FDA’s granting of Fast Track Designation (“FTD”) for REQORSA Immunogene Therapy in combination with Tecentriq in patients with ES-SCLC who did not develop tumor progression after receiving Tecentriq and chemotherapy as initial standard treatment. “With…

FridaySep 15, 2023 12:19 pm

QualityStocksNewsBreaks – Fintech Ecosystem Development Corp. (NASDAQ: FEXD) Tapping Emerging Technologies to Address Unmet Mobile Money Needs

Fintech Ecosystem Development Corp. (NASDAQ: FEXD) is working to develop a global financial technology ecosystem. “The company is keen on addressing unmet mobile money needs in developing and industrialized markets and making mobile transactions easier and more affordable. To turn its vision into a reality, FEXD is adopting emerging technologies like artificial intelligence (‘AI’),” a recent article reads. “Given the role AI has historically played in helping companies detect, measure and manage risk, it is still being called upon to deal with financial crime and cyber threats and detect fraud. In addition, and alongside these crucial applications of the technology,…

FridaySep 15, 2023 12:10 pm

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Optimistic Berubicin May Provide Much-Needed Benefit for GBM Patients

CNS Pharmaceuticals (NASDAQ: CNSP), a clinical-stage biotechnology company specializing in the development of novel treatments with a focus on brain cancer, glioblastoma (“GBM”) and neuro-oncology, recently presented updated safety results from its potentially pivotal clinical study on GBM treatment through its lead drug candidate, Berubicin. “Most notably, this novel anthracycline demonstrated its capability to be a safe and innovative potential treatment option for GBM, having shown aspects integral to effective therapy for the disease… So far, 151 patients have been enrolled in the clinical study, with 105 set on Berubicin while the remaining 46 will be on Lomustine. This marks…

FridaySep 15, 2023 11:58 am

QualityStocksNewsBreaks – Safety Shot (NASDAQ: SHOT) Rebrands with New Name, Ticker to Focus on New Business

Safety Shot (NASDAQ: SHOT), formerly known as Jupiter Wellness, has announced that effective today it has changed its name to Safety Shot; its ticker will also change to SHOT. The changes come after the company acquired Safety Shot, the first patented beverage that helps a person feel better faster by reducing blood alcohol content while also boosting clarity. The new beverage is currently being produced in the United States and will be available in the Q4 2023. Safety Shot is a patented beverage that helps to break down alcohol faster which aids in aiding in recovery and rehydration. Safety Shot is creating…

FridaySep 15, 2023 11:47 am

QualityStocksNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Announces $1.33M Registered Direct

Scinai Immunotherapeutics (NASDAQ: SCNI) is a biopharmaceutical company focused on developing, manufacturing and commercializing innovative inflammation and immunology (“I&I”) biological products primarily for the treatment of autoimmune and infectious diseases. The company today announced its entry into a definitive agreement for the purchase and sale of 1,146,552 of the company’s American Depositary Shares (“ADSs”) (or ADS equivalents), each ADS representing 400 ordinary shares, at a purchase price of yesterday’s closing price of $1.16 per ADS (or ADS equivalent), in a registered direct offering. In addition, the company will issue unregistered warrants to purchase up to 1,146,552 ADSs representing ordinary shares…

FridaySep 15, 2023 10:11 am

QualityStocksNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Leveraging Technology, Innovative Services to Enhance US Safety

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots and blue light emergency communication systems, is leveraging technology to improve public safety across the U.S. utilizing Amazon.com Inc.’s (NASDAQ: AMZN) Amazon Web Services (“AWS”). The announcement reads, “In Huntington Park, California, Knightscope’s K5 Autonomous Security Robot (‘ASR’) helped reduce calls for service by 10% and crime reports by 46% during its first year of deployment. The city council subsequently voted unanimously to extend their contract and has recently awarded Knightscope a contract for its 5th year of service. Knightscope leveraged nearly a dozen AWS services to support this project.…

FridaySep 15, 2023 8:30 am

QualityStocksNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) CEO Spotlighted in Recent ‘Bloomberg Technology’ Segment

D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software and services, was featured in the “Bloomberg Technology” daily news program earlier this week. During the insightful interview, D-Wave Quantum CEO Alan Baratz talked with host Ed Ludlow about the future of quantum computing, noting that quantum computing has the potential to transform how businesses operate. Baratz also discussed competition between the United States and China as well as the impact of artificial intelligence (“AI”) on the sector. A New York Stock Exchange listed U.S. company, D-Wave is the world's first company to develop a commercial quantum computer that…

ThursdaySep 14, 2023 3:45 pm

QualityStocksNewsBreaks – First Tellurium Corp. (CSE: FTEL) (OTC: FSTTF) in Unique ‘Only Ones in Town’ Position

First Tellurium (CSE: FTEL) (OTC: FSTTF) president and CEO Tyron Docherty was recently featured as a guest on the Bell2Bell podcast, where he talked about the company and its key position in the growing tellurium space. “First Tellurium has a wonderful, high-grade gold and silver property in Canada, but it comes with this unique mineral, tellurium, which is listed by both the United States and Canadian governments as critical,” a recent article quotes Docherty as saying. “Tellurium has come into the fore over the last couple of decades because it is used in solar panels by U.S. corporation First Solar,…

ThursdaySep 14, 2023 1:43 pm

QualityStocksNewsBreaks – Lucy Scientific Discovery Inc. (NASDAQ: LSDI) Collaborates to Unlock the Value of Brands Through Strategic Acquisitions

Lucy Scientific Discovery (NASDAQ: LSDI), a publicly traded company focused on the development, sale, delivery, and manufacturing of psychotropic products, recently announced the acquisition of BlueSky Wellness Inc., along with its portfolio of brands, which adds psychotropic products to its catalog and expands its footprint into the global wellness market. BlueSky wellness-focused ecommerce brands include Keoni, Keoni Sport, Blush Wellness and AMMA Healing, which, in each of the last two years, have generated over $20 million in revenue. BlueSky is poised with a variety of products that range from full-spectrum oils to edible goods, gummies, topicals and beauty products. The…

Site Search

Company Search

Category: QualityStocksNewsBreaks